Francese Rachele, Donalisio Manuela, Rittà Massimo, Capitani Federica, Mantovani Veronica, Maccari Francesca, Tonetto Paola, Moro Guido E, Bertino Enrico, Volpi Nicola, Lembo David
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, Orbassano (TO), Italy.
Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Pediatr Res. 2022 May 5. doi: 10.1038/s41390-022-02091-y.
The antiviral role of glycosaminoglycans in human milk (HM-GAGs) has been poorly investigated. They are highly sulfated polysaccharides, which were proposed to act as decoy receptors according to their structure. The aim of this study is to evaluate the antiviral potential and the mechanism of action of total and individual HM-GAGs against three pediatric clinically relevant viruses: respiratory syncytial virus (RSV), cytomegalovirus (HCMV), and rotavirus.
HM-GAGs were isolated from HM and a library of individual GAGs, structurally related to HM-GAGs, was prepared. The antiviral activity of HM-GAGs and the impact of thermal treatment were investigated in vitro by specific antiviral assays.
We demonstrated that HM-GAGs are endowed with anti-HCMV and anti-RSV activity and that they act by altering virus attachment to cell. We clarified the contribution of individual HM-GAGs, showing a specific structure-related activity. We did not observe any alteration of HM-GAG antiviral activity after thermal treatment.
We showed that HM-GAGs contribute to the overall antiviral activity of HM, likely exerting a synergic action with other HM antiviral agents. HM-GAGs can now be added to the list of endogenous factors that may reduce breast-milk-acquired HCMV symptomatic infections and protecting infants from respiratory tract infections by RSV.
HM-GAGs have been poorly investigated for their antiviral action so far. We demonstrated that HM-GAGs are endowed with significant anti-HCMV and anti-RSV activity and that they are able to alter virus binding to the cell. The contribution of individual HM-GAGs is mainly exerted by the FMHep and is not based on a simple charge interaction between the virus and sulfate groups but involves a specific GAG structural configuration. Our results contribute to identifying the multiple factors synergically acting in mediating HM antiviral properties and to clarifying their specific mechanism of action.
人乳中糖胺聚糖(HM-GAGs)的抗病毒作用研究较少。它们是高度硫酸化的多糖,根据其结构被认为可作为诱饵受体。本研究的目的是评估总HM-GAGs和单个HM-GAGs对三种儿科临床相关病毒的抗病毒潜力及作用机制:呼吸道合胞病毒(RSV)、巨细胞病毒(HCMV)和轮状病毒。
从人乳中分离出HM-GAGs,并制备了一个与HM-GAGs结构相关的单个GAGs文库。通过特定的抗病毒试验在体外研究了HM-GAGs的抗病毒活性及热处理的影响。
我们证明了HM-GAGs具有抗HCMV和抗RSV活性,且它们通过改变病毒与细胞的附着起作用。我们阐明了单个HM-GAGs的作用,显示出特定的结构相关活性。热处理后,我们未观察到HM-GAGs抗病毒活性有任何改变。
我们表明HM-GAGs有助于人乳的整体抗病毒活性,可能与其他母乳抗病毒剂发挥协同作用。现在可以将HM-GAGs添加到可能减少母乳获得性HCMV症状性感染并保护婴儿免受RSV引起的呼吸道感染的内源性因素列表中。
迄今为止,对HM-GAGs的抗病毒作用研究较少。我们证明了HM-GAGs具有显著的抗HCMV和抗RSV活性,并且它们能够改变病毒与细胞的结合。单个HM-GAGs的作用主要由FMHep发挥,并非基于病毒与硫酸基团之间简单的电荷相互作用,而是涉及特定的GAG结构构型。我们的结果有助于确定在介导母乳抗病毒特性中协同作用的多种因素,并阐明其具体作用机制。